On Monday shares of Rite Aid Corporation (NYSE:RAD) closed at $8.14. Company’s sales growth for last 5 years was -0.60% and EPS growth for next 5 years is recorded as 39.71%. Rite Aid Corporation (NYSE:RAD) has some great deals starting 3/22 including Dove shampoo, conditioner or stylers (FREE!), Irish spring body wash, Odor Eaters (FREE!), Tresemme (.74!), Xtra laundry detergent, Huggies, M&M’s, Prescription coupon and more!
MEI Pharma, Inc. (NASDAQ:MEIP) in last trading activity moved down -69.37% to close at $1.93. Company weekly performance is -68.10% while its quarterly performance stands at -53.27%. MEI Pharma, Inc. (NASDAQ:MEIP) is -86.19% away from its 52 week high. MEI Pharma (NASDAQ:MEIP) announced top-line data from a randomized Phase II clinical study of its investigational drug candidate Pracinostat in combination with azacitidine in patients with previously untreated intermediate-2 or high-risk myelodysplastic syndrome (MDS) … According to the top-line data, the combination of Pracinostat and azacitidine showed no difference in the rate of complete remission (CR), the study’s primary endpoint, compared to azacitidine alone.
On Monday shares of Bristol-Myers Squibb Company (NYSE:BMY) closed at $67.58. Company’s sales growth for last 5 years was -3.30% and EPS growth for next 5 years is recorded as 16.21%. Bristol-Myers Squibb Company (NYSE:BMY) has received an “AA-” credit rating from analysts at Morningstar. The firm’s “AA-” rating indicates that the company is a very-low default risk. They also gave their stock a three star rating.
Johnson & Johnson (NYSE:JNJ) in last trading activity advanced 0.57% to close at $102.98. Company weekly performance is 1.90% while its quarterly performance stands at -2.91%. Johnson & Johnson (NYSE:JNJ) is -4.85% away from its 52 week high. Lawyers at Covington & Burling scored a victory for Johnson & Johnson (NYSE:JNJ) on Friday in a patent fight over Concerta, the company’s blockbuster drug to treat attention deficit hyperactivity disorder. U.S. District Judge Phyllis Hamilton of the Northern District of California knocked out the patent suit brought by a doctor claiming to be coinventor of the drug.
On last trading day Barrett Business Services Inc. (NASDAQ:BBSI) advanced 0.40% to close at $42.89. Its volatility for the week is 3.48% while volatility for the month is 3.86%. BBSI’s sales growth for past 5 years was 21.90% and its EPS growth for past 5 years was -58.30%. Barrett Business Services Inc. (NASDAQ:BBSI) monthly performance is 11.20%. Barrett Business Services, Inc. (NASDAQ:BBSI) presented at the 27th Annual ROTH Capital Partners Conference, which hold on March 9-11, 2015 at The Ritz-Carlton, Laguna Niguel in Dana Point, California.